F Megerlin

Summary

Publications

  1. doi request reprint [Faecal microbiota transplantation in France: what applicable law?]
    F Megerlin
    Service de droit et d économie de la santé, Faculte des Sciences Pharmaceutiques et Biologiques, Universite Paris Descartes, 4, avenue de l Observatoire, 75006 Paris, France Berkeley Center for Health Technology, University of California, Berkeley, États Unis GRADES université Paris Sud, 5, rue Jean Baptiste Clement, 92296 Chatenay Malabry Cedex, France Académie nationale de pharmacie, 4, avenue de l Observatoire, 75006 Paris, France Electronic address
    Ann Pharm Fr 72:363-74. 2014
  2. doi request reprint Faecal microbiota transplantation: a sui generis biological drug, not a tissue
    F Megerlin
    Department of Health Law and Economics, School of Pharmacy, University Paris Descartes, 4, avenue de l Observatoire, 75006 Paris, France Berkeley Center for Health Technology, University of California, Berkeley, CA, United States GRADES University of Paris Sud, 5, rue Jean Baptiste Clement, 92296 Chatenay Malabry Cedex, France Académie nationale de pharmacie, 4, avenue de l Observatoire, 75006 Paris, France Electronic address
    Ann Pharm Fr 72:217-20. 2014
  3. doi request reprint [Conditional pricing for innovative medicines in France: stop telling about risk-sharing!]
    F Megerlin
    Service de droit et d économie de la santé, Faculte des Sciences Pharmaceutiques et Biologiques, Universite Paris Descartes, 4, avenue de l Observatoire, 75006, Paris, France Berkeley Center for Health Technology, University of California, Berkeley, États Unis GRADES, Faculte de Pharmacie, Universite Paris Sud, 5, rue Jean Baptiste Clement, 92296, Chatenay Malabry Cedex, France Electronic address
    Ann Pharm Fr 71:291-301. 2013
  4. doi request reprint [Vaccination and French community pharmacists: from innovative actions to innovative organisations?]
    F Megerlin
    Service de droit et d économie de la santé, Faculte des Sciences Pharmaceutiques et Biologiques, Universite Paris Descartes, 4, avenue de l Observatoire, 75006 Paris, France
    Ann Pharm Fr 70:323-32. 2012

Detail Information

Publications4

  1. doi request reprint [Faecal microbiota transplantation in France: what applicable law?]
    F Megerlin
    Service de droit et d économie de la santé, Faculte des Sciences Pharmaceutiques et Biologiques, Universite Paris Descartes, 4, avenue de l Observatoire, 75006 Paris, France Berkeley Center for Health Technology, University of California, Berkeley, États Unis GRADES université Paris Sud, 5, rue Jean Baptiste Clement, 92296 Chatenay Malabry Cedex, France Académie nationale de pharmacie, 4, avenue de l Observatoire, 75006 Paris, France Electronic address
    Ann Pharm Fr 72:363-74. 2014
    ..A new category of therapeutic products could be considered in European law, unless a rapid technological progress (the French Agency ASNM classified FMT as a drug in March 2014). ..
  2. doi request reprint Faecal microbiota transplantation: a sui generis biological drug, not a tissue
    F Megerlin
    Department of Health Law and Economics, School of Pharmacy, University Paris Descartes, 4, avenue de l Observatoire, 75006 Paris, France Berkeley Center for Health Technology, University of California, Berkeley, CA, United States GRADES University of Paris Sud, 5, rue Jean Baptiste Clement, 92296 Chatenay Malabry Cedex, France Académie nationale de pharmacie, 4, avenue de l Observatoire, 75006 Paris, France Electronic address
    Ann Pharm Fr 72:217-20. 2014
    ....
  3. doi request reprint [Conditional pricing for innovative medicines in France: stop telling about risk-sharing!]
    F Megerlin
    Service de droit et d économie de la santé, Faculte des Sciences Pharmaceutiques et Biologiques, Universite Paris Descartes, 4, avenue de l Observatoire, 75006, Paris, France Berkeley Center for Health Technology, University of California, Berkeley, États Unis GRADES, Faculte de Pharmacie, Universite Paris Sud, 5, rue Jean Baptiste Clement, 92296, Chatenay Malabry Cedex, France Electronic address
    Ann Pharm Fr 71:291-301. 2013
    ..They also should not impact the national list prices of medicines, that is a decisive tool for stabilizing international trade. ..
  4. doi request reprint [Vaccination and French community pharmacists: from innovative actions to innovative organisations?]
    F Megerlin
    Service de droit et d économie de la santé, Faculte des Sciences Pharmaceutiques et Biologiques, Universite Paris Descartes, 4, avenue de l Observatoire, 75006 Paris, France
    Ann Pharm Fr 70:323-32. 2012
    ..It would allow to release and to value medical and nursing time for the benefit of patients. Thanks to gain-sharing organizations, healthcare providers could explore dynamic cooperation...